Insurmountable AT 1 receptor antagonism: the need for different antagonist binding states of the receptor

By Vauquelin G.   Fierens F.   Verheijen I.   Vanderheyden P.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 7, 2001-07 ,pp. : 343-344

Elsevier

Access to resources Recommend Favorite

Insurmountable AT 1 receptor antagonism: fitting models with experimental data

By Vauquelin G.   FierensIlse F.   Vanderheyden V.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 11, 2001-11 ,pp. : 557-557

Elsevier

Access to resources Recommend Favorite

Models and methods for studying insurmountable antagonism

By Vauquelin G.   Van Liefde I.   Vanderheyden P.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 11, 2002-11 ,pp. : 514-518

Elsevier

Access to resources Recommend Favorite

Insurmountable angiotensin AT 1 receptor antagonists: the role of tight antagonist binding

By Fierens F.L.P.   Vanderheyden P.M.L.   De Backer J.-P.   Vauquelin G.  

European Journal of Pharmacology, Vol. 372, Iss. 2, 1999-05 ,pp. : 199-206

Elsevier

Access to resources Recommend Favorite

Effects of the insurmountable angiotensin AT 1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts

By Wang Q.-D.   Sjoquist P.-O.  

European Journal of Pharmacology, Vol. 380, Iss. 1, 1999-09 ,pp. : 13-21

Elsevier

Access to resources Recommend Favorite